{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T11:34:46Z","timestamp":1791891286523,"version":"4.3.4"},"reference-count":83,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2010,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Surgically correctable forms of primary aldosteronism are characterized by unilateral aldosterone hypersecretion and renin suppression, associated with varying degrees of hypertension and hypokalemia. Unilateral aldosterone hypersecretion is caused by an aldosterone-producing adenoma (also known as Conn's adenoma and aldosteronoma), primary unilateral adrenal hyperplasia and rare cases of aldosterone-producing adrenocortical carcinoma. In these forms, unilateral adrenalectomy can cure aldosterone excess and hypokalemia, but not necessarily hypertension. The prevalence of primary aldosteronism in the general population is not known. Its prevalence in referred hypertensive populations is estimated to be between 6 and 13%, of which 1.5 to 5% have an aldosterone-producing adenoma or primary unilateral adrenal hyperplasia. Taking into account referral biases, the prevalence of surgically correctable primary aldosteronism is probably less than 1.5% in the hypertensive population and less than 0.3% in the general adult population. Surgically correctable primary aldosteronism is sought in patients with hypokalemic, severe or resistant forms of hypertension. Recent recommendations suggest screening for primary aldosteronism using the aldosterone to renin ratio. Patients with a raised ratio then undergo confirmatory suppression tests. The differential diagnosis of hypokalemic hypertension with low renin includes mineralocorticoid excess, with the mineralocorticoid being cortisol or 11-deoxycorticosterone, apparent mineralocorticoid excess, pseudo-hypermineralocorticoidism in Liddle syndrome or exposure to glycyrrhizic acid. Once the diagnosis is confirmed, adrenal computed tomography is performed for all patients. If surgery is considered, taking into consideration the clinical context and the desire of the patient, adrenal vein sampling is performed to detect whether or not aldosterone hypersecretion is unilateral. Laparoscopic surgery for unilateral aldosterone hypersecretion is associated with a morbidity of about 8%, with most complications being minor. It generally results in the normalization of aldosterone secretion and kalemia, and in a large decrease in blood pressure, but normotension without treatment is only achieved in half of all cases. Normotension following adrenalectomy is more frequent in young patients with recent hypertension than in patients with long-standing hypertension or a family history of hypertension.<\/jats:p>","DOI":"10.1186\/1750-1172-5-9","type":"journal-article","created":{"date-parts":[[2010,5,19]],"date-time":"2010-05-19T18:14:19Z","timestamp":1274292859000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":68,"title":["Aldosterone-producing adenoma and other surgically correctable forms of primary aldosteronism"],"prefix":"10.1186","volume":"5","author":[{"given":"Laurence","family":"Amar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre-Fran\u00e7ois","family":"Plouin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Steichen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,5,19]]},"reference":[{"key":"172_CR1","first-page":"3","volume":"45","author":"JW Conn","year":"1955","unstructured":"Conn JW: Presidential address. I. Painting background. II. Primary aldosteronism, a new clinical syndrome. J Lab Clin Med. 1955, 45: 3-17.","journal-title":"J Lab Clin Med"},{"key":"172_CR2","first-page":"213","volume":"190","author":"JW Conn","year":"1964","unstructured":"Conn JW, Cohen EL, Rovner DR: Suppression of Plasma Renin Activity in Primary Aldosteronism. Jama. 1964, 190: 213-21.","journal-title":"Jama"},{"key":"172_CR3","doi-asserted-by":"publisher","first-page":"3266","DOI":"10.1210\/jc.2008-0104","volume":"93","author":"JW Funder","year":"2008","unstructured":"Funder JW, Carey RM, Fardella C, et al: Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2008, 93: 3266-81. 10.1210\/jc.2008-0104.","journal-title":"J Clin Endocrinol Metab"},{"key":"172_CR4","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1161\/01.HYP.0000258554.87444.91","volume":"49","author":"C Newton-Cheh","year":"2007","unstructured":"Newton-Cheh C, Guo CY, Gona P, et al: Clinical and genetic correlates of aldosterone-to-renin ratio and relations to blood pressure in a community sample. Hypertension. 2007, 49: 846-56. 10.1161\/01.HYP.0000258554.87444.91.","journal-title":"Hypertension"},{"issue":"Suppl 1","key":"172_CR5","doi-asserted-by":"publisher","first-page":"83s","DOI":"10.1016\/S0753-3322(00)80019-0","volume":"54","author":"T Nishikawa","year":"2000","unstructured":"Nishikawa T, Omura M: Clinical characteristics of primary aldosteronism: its prevalence and comparative studies on various causes of primary aldosteronism in Yokohama Rosai Hospital. Biomed Pharmacother. 2000, 54 (Suppl 1): 83s-5s. 10.1016\/S0753-3322(00)80019-0.","journal-title":"Biomed Pharmacother"},{"key":"172_CR6","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1210\/jc.2003-031337","volume":"89","author":"P Mulatero","year":"2004","unstructured":"Mulatero P, Stowasser M, Loh KC, et al: Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents. J Clin Endocrinol Metab. 2004, 89: 1045-50. 10.1210\/jc.2003-031337.","journal-title":"J Clin Endocrinol Metab"},{"key":"172_CR7","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1016\/j.jacc.2006.07.059","volume":"48","author":"GP Rossi","year":"2006","unstructured":"Rossi GP, Bernini G, Caliumi C, et al: A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients. J Am Coll Cardiol. 2006, 48: 2293-300. 10.1016\/j.jacc.2006.07.059.","journal-title":"J Am Coll Cardiol"},{"key":"172_CR8","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1291\/hypres.30.111","volume":"30","author":"R Fogari","year":"2007","unstructured":"Fogari R, Preti P, Zoppi A, Rinaldi A, Fogari E, Mugellini A: Prevalence of primary aldosteronism among unselected hypertensive patients: a prospective study based on the use of an aldosterone\/renin ratio above 25 as a screening test. Hypertens Res. 2007, 30: 111-7. 10.1291\/hypres.30.111.","journal-title":"Hypertens Res"},{"key":"172_CR9","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1016\/S0140-6736(08)60834-X","volume":"371","author":"S Douma","year":"2008","unstructured":"Douma S, Petidis K, Doumas M, et al: Prevalence of primary hyperaldosteronism in resistant hypertension: a retrospective observational study. Lancet. 2008, 371: 1921-6. 10.1016\/S0140-6736(08)60834-X.","journal-title":"Lancet"},{"key":"172_CR10","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/S0895-7061(02)02969-2","volume":"15","author":"E Rossi","year":"2002","unstructured":"Rossi E, Regolisti G, Negro A, Sani C, Davoli S, Perazzoli F: High prevalence of primary aldosteronism using postcaptopril plasma aldosterone to renin ratio as a screening test among Italian hypertensives. Am J Hypertens. 2002, 15: 896-902. 10.1016\/S0895-7061(02)02969-2.","journal-title":"Am J Hypertens"},{"key":"172_CR11","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/S0140-6736(05)70151-3","volume":"365","author":"PM Kearney","year":"2005","unstructured":"Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J: Global burden of hypertension: analysis of worldwide data. Lancet. 2005, 365: 217-23.","journal-title":"Lancet"},{"key":"172_CR12","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/S0022-3468(96)90753-8","volume":"31","author":"A Abasiyanik","year":"1996","unstructured":"Abasiyanik A, Oran B, Kaymakci A, Yasar C, Caliskan U, Erkul I: Conn syndrome in a child, caused by adrenal adenoma. J Pediatr Surg. 1996, 31: 430-2. 10.1016\/S0022-3468(96)90753-8.","journal-title":"J Pediatr Surg"},{"key":"172_CR13","first-page":"187","volume":"2","author":"GS Andersen","year":"1988","unstructured":"Andersen GS, Toftdahl DB, Lund JO, Strandgaard S, Nielsen PE: The incidence rate of phaeochromocytoma and Conn's syndrome in Denmark, 1977-1981. J Hum Hypertens. 1988, 2: 187-9.","journal-title":"J Hum Hypertens"},{"issue":"Suppl 1","key":"172_CR14","doi-asserted-by":"publisher","first-page":"164s","DOI":"10.1016\/S0753-3322(00)80036-0","volume":"54","author":"R Takayanagi","year":"2000","unstructured":"Takayanagi R, Miura K, Nakagawa H, Nawata H: Epidemiologic study of adrenal gland disorders in Japan. Biomed Pharmacother. 2000, 54 (Suppl 1): 164s-8s. 10.1016\/S0753-3322(00)80036-0.","journal-title":"Biomed Pharmacother"},{"key":"172_CR15","first-page":"987","volume":"112","author":"T Obara","year":"1992","unstructured":"Obara T, Ito Y, Okamoto T, et al: Risk factors associated with postoperative persistent hypertension in patients with primary aldosteronism. Surgery. 1992, 112: 987-93.","journal-title":"Surgery"},{"key":"172_CR16","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/S0022-5347(17)35781-6","volume":"150","author":"PE Gleason","year":"1993","unstructured":"Gleason PE, Weinberger MH, Pratt JH, et al: Evaluation of diagnostic tests in the differential diagnosis of primary aldosteronism: unilateral adenoma versus bilateral micronodular hyperplasia. J Urol. 1993, 150: 1365-8.","journal-title":"J Urol"},{"key":"172_CR17","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1067\/msy.1998.93108","volume":"124","author":"CA Proye","year":"1998","unstructured":"Proye CA, Mulliez EA, Carnaille BM, et al: Essential hypertension: first reason for persistent hypertension after unilateral adrenalectomy for primary aldosteronism?. Surgery. 1998, 124: 1128-33. 10.1067\/msy.1998.93108.","journal-title":"Surgery"},{"key":"172_CR18","doi-asserted-by":"publisher","first-page":"258","DOI":"10.7326\/0003-4819-135-4-200108210-00010","volume":"135","author":"AM Sawka","year":"2001","unstructured":"Sawka AM, Young WF, Thompson GB, et al: Primary aldosteronism: factors associated with normalization of blood pressure after surgery. Ann Intern Med. 2001, 135: 258-61.","journal-title":"Ann Intern Med"},{"key":"172_CR19","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1177\/000313480507101015","volume":"71","author":"F Lumachi","year":"2005","unstructured":"Lumachi F, Ermani M, Basso SM, Armanini D, Iacobone M, Favia G: Long-term results of adrenalectomy in patients with aldosterone-producing adenomas: multivariate analysis of factors affecting unresolved hypertension and review of the literature. Am Surg. 2005, 71: 864-9.","journal-title":"Am Surg"},{"key":"172_CR20","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1111\/j.1445-2197.2007.04225.x","volume":"77","author":"TC Pang","year":"2007","unstructured":"Pang TC, Bambach C, Monaghan JC, et al: Outcomes of laparoscopic adrenalectomy for hyperaldosteronism. ANZ J Surg. 2007, 77: 768-73. 10.1111\/j.1445-2197.2007.04225.x.","journal-title":"ANZ J Surg"},{"key":"172_CR21","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1161\/HYPERTENSIONAHA.108.111369","volume":"51","author":"GP Rossi","year":"2008","unstructured":"Rossi GP, Bolognesi M, Rizzoni D, et al: Vascular remodeling and duration of hypertension predict outcome of adrenalectomy in primary aldosteronism patients. Hypertension. 2008, 51: 1366-71. 10.1161\/HYPERTENSIONAHA.108.111369.","journal-title":"Hypertension"},{"key":"172_CR22","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1097\/HJH.0b013e3283060f0c","volume":"26","author":"E Letavernier","year":"2008","unstructured":"Letavernier E, Peyrard S, Amar L, Zinzindohoue F, Fiquet B, Plouin PF: Blood pressure outcome of adrenalectomy in patients with primary hyperaldosteronism with or without unilateral adenoma. J Hypertens. 2008, 26: 1816-23. 10.1097\/HJH.0b013e3283060f0c.","journal-title":"J Hypertens"},{"key":"172_CR23","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.jvir.2007.08.022","volume":"19","author":"R Zarnegar","year":"2008","unstructured":"Zarnegar R, Bloom AI, Lee J, et al: Is adrenal venous sampling necessary in all patients with hyperaldosteronism before adrenalectomy?. J Vasc Interv Radiol. 2008, 19: 66-71. 10.1016\/j.jvir.2007.08.022.","journal-title":"J Vasc Interv Radiol"},{"key":"172_CR24","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1097\/SLA.0b013e318165c075","volume":"247","author":"R Zarnegar","year":"2008","unstructured":"Zarnegar R, Young WF, Lee J, et al: The aldosteronoma resolution score: predicting complete resolution of hypertension after adrenalectomy for aldosteronoma. Ann Surg. 2008, 247: 511-8. 10.1097\/SLA.0b013e318165c075.","journal-title":"Ann Surg"},{"key":"172_CR25","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1161\/01.HYP.0000040261.30455.B6","volume":"40","author":"DA Calhoun","year":"2002","unstructured":"Calhoun DA, Nishizaka MK, Zaman MA, Thakkar RB, Weissmann P: Hyperaldosteronism among black and white subjects with resistant hypertension. Hypertension. 2002, 40: 892-6. 10.1161\/01.HYP.0000040261.30455.B6.","journal-title":"Hypertension"},{"key":"172_CR26","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1097\/HJH.0b013e3282f0580f","volume":"25","author":"G Mancia","year":"2007","unstructured":"Mancia G, De Backer G, Dominiczak A, et al: 2007 ESH-ESC Practice Guidelines for the Management of Arterial Hypertension: ESH-ESC Task Force on the Management of Arterial Hypertension. J Hypertens. 2007, 25: 1751-62. 10.1097\/HJH.0b013e3282f0580f.","journal-title":"J Hypertens"},{"key":"172_CR27","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1111\/j.1365-2265.2008.03213.x","volume":"69","author":"V Medeau","year":"2008","unstructured":"Medeau V, Moreau F, Trinquart L, et al: Clinical and biochemical characteristics of normotensive patients with primary aldosteronism: a comparison with hypertensive cases. Clin Endocrinol (Oxf). 2008, 69: 20-8. 10.1111\/j.1365-2265.2008.03213.x.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"172_CR28","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1210\/jc.85.2.637","volume":"85","author":"F Mantero","year":"2000","unstructured":"Mantero F, Terzolo M, Arnaldi G, et al: A survey on adrenal incidentaloma in Italy. Study Group on Adrenal Tumors of the Italian Society of Endocrinology. J Clin Endocrinol Metab. 2000, 85: 637-44. 10.1210\/jc.85.2.637.","journal-title":"J Clin Endocrinol Metab"},{"key":"172_CR29","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1161\/HYPERTENSIONAHA.109.139832","volume":"55","author":"GP Rossi","year":"2009","unstructured":"Rossi GP, Seccia TM, Palumbo G, et al: Within-patient reproducibility of the aldosterone: renin ratio in primary aldosteronism. Hypertension. 2009, 55: 83-9. 10.1161\/HYPERTENSIONAHA.109.139832.","journal-title":"Hypertension"},{"key":"172_CR30","doi-asserted-by":"publisher","first-page":"2489","DOI":"10.1210\/jc.2002-021476","volume":"88","author":"A Tanabe","year":"2003","unstructured":"Tanabe A, Naruse M, Takagi S, Tsuchiya K, Imaki T, Takano K: Variability in the renin\/aldosterone profile under random and standardized sampling conditions in primary aldosteronism. J Clin Endocrinol Metab. 2003, 88: 2489-94. 10.1210\/jc.2002-021476.","journal-title":"J Clin Endocrinol Metab"},{"key":"172_CR31","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1001\/archinte.1981.00340130033011","volume":"141","author":"K Hiramatsu","year":"1981","unstructured":"Hiramatsu K, Yamada T, Yukimura Y, et al: A screening test to identify aldosterone-producing adenoma by measuring plasma renin activity. Results in hypertensive patients. Arch Intern Med. 1981, 141: 1589-93. 10.1001\/archinte.141.12.1589.","journal-title":"Arch Intern Med"},{"key":"172_CR32","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1373\/clinchem.2008.118000","volume":"55","author":"DJ Campbell","year":"2009","unstructured":"Campbell DJ, Nussberger J, Stowasser M, et al: Activity assays and immunoassays for plasma Renin and prorenin: information provided and precautions necessary for accurate measurement. Clin Chem. 2009, 55: 867-77. 10.1373\/clinchem.2008.118000.","journal-title":"Clin Chem"},{"key":"172_CR33","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/S0889-8529(02)00013-0","volume":"31","author":"VM Montori","year":"2002","unstructured":"Montori VM, Young WF: Use of plasma aldosterone concentration-to-plasma renin activity ratio as a screening test for primary aldosteronism. A systematic review of the literature. Endocrinol Metab Clin North Am. 2002, 31: 619-32. 10.1016\/S0889-8529(02)00013-0. xi.","journal-title":"Endocrinol Metab Clin North Am"},{"key":"172_CR34","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/S0272-6386(01)80117-7","volume":"37","author":"BJ Gallay","year":"2001","unstructured":"Gallay BJ, Ahmad S, Xu L, Toivola B, Davidson RC: Screening for primary aldosteronism without discontinuing hypertensive medications: plasma aldosterone-renin ratio. Am J Kidney Dis. 2001, 37: 699-705. 10.1016\/S0272-6386(01)80117-7.","journal-title":"Am J Kidney Dis"},{"key":"172_CR35","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1161\/01.HYP.0000038478.59760.41","volume":"40","author":"P Mulatero","year":"2002","unstructured":"Mulatero P, Rabbia F, Milan A, et al: Drug effects on aldosterone\/plasma renin activity ratio in primary aldosteronism. Hypertension. 2002, 40: 897-902. 10.1161\/01.HYP.0000038478.59760.41.","journal-title":"Hypertension"},{"key":"172_CR36","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1055\/s-2008-1065336","volume":"40","author":"HS Willenberg","year":"2008","unstructured":"Willenberg HS, Schinner S, Ansurudeen I: New mechanisms to control aldosterone synthesis. Horm Metab Res. 2008, 40: 435-41. 10.1055\/s-2008-1065336.","journal-title":"Horm Metab Res"},{"key":"172_CR37","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1016\/j.amjhyper.2007.08.009","volume":"20","author":"F Pizzolo","year":"2007","unstructured":"Pizzolo F, Pavan C, Corrocher R, Olivieri O: Laboratory diagnosis of primary aldosteronism, and drospirenone-ethinylestradiol therapy. Am J Hypertens. 2007, 20: 1334-7. 10.1016\/j.amjhyper.2007.08.009.","journal-title":"Am J Hypertens"},{"key":"172_CR38","first-page":"S103","volume":"5","author":"RD Gordon","year":"1987","unstructured":"Gordon RD, Gomez-Sanchez CE, Hamlet SM, Tunny TJ, Klemm SA: Angiotensin-responsive aldosterone-producing adenoma masquerades as idiopathic hyperaldosteronism (IHA: adrenal hyperplasia) or low-renin essential hypertension. J Hypertens Suppl. 1987, 5: S103-6.","journal-title":"J Hypertens Suppl"},{"key":"172_CR39","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1093\/ajh\/3.7.576","volume":"3","author":"I Irony","year":"1990","unstructured":"Irony I, Kater CE, Biglieri EG, Shackleton CH: Correctable subsets of primary aldosteronism. Primary adrenal hyperplasia and renin responsive adenoma. Am J Hypertens. 1990, 3: 576-82.","journal-title":"Am J Hypertens"},{"key":"172_CR40","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1097\/HJH.0b013e328126856e","volume":"25","author":"GP Rossi","year":"2007","unstructured":"Rossi GP, Belfiore A, Bernini G, et al: Prospective evaluation of the saline infusion test for excluding primary aldosteronism due to aldosterone-producing adenoma. J Hypertens. 2007, 25: 1433-42. 10.1097\/HJH.0b013e328126856e.","journal-title":"J Hypertens"},{"key":"172_CR41","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1038\/sj.jhh.1001948","volume":"20","author":"JS Williams","year":"2006","unstructured":"Williams JS, Williams GH, Raji A, et al: Prevalence of primary hyperaldosteronism in mild to moderate hypertension without hypokalaemia. J Hum Hypertens. 2006, 20: 129-36. 10.1038\/sj.jhh.1001948.","journal-title":"J Hum Hypertens"},{"key":"172_CR42","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1111\/j.1365-2265.2007.02775.x","volume":"66","author":"WF Young","year":"2007","unstructured":"Young WF: Primary aldosteronism: renaissance of a syndrome. Clin Endocrinol (Oxf). 2007, 66: 607-18. 10.1111\/j.1365-2265.2007.02775.x.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"172_CR43","doi-asserted-by":"publisher","first-page":"4292","DOI":"10.1210\/jcem.86.9.7867","volume":"86","author":"D Hirohara","year":"2001","unstructured":"Hirohara D, Nomura K, Okamoto T, Ujihara M, Takano K: Performance of the basal aldosterone to renin ratio and of the renin stimulation test by furosemide and upright posture in screening for aldosterone-producing adenoma in low renin hypertensives. J Clin Endocrinol Metab. 2001, 86: 4292-8. 10.1210\/jc.86.9.4292.","journal-title":"J Clin Endocrinol Metab"},{"key":"172_CR44","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.mce.2003.10.006","volume":"217","author":"M Stowasser","year":"2004","unstructured":"Stowasser M, Gordon RD: Primary aldosteronism--careful investigation is essential and rewarding. Mol Cell Endocrinol. 2004, 217: 33-9. 10.1016\/j.mce.2003.10.006.","journal-title":"Mol Cell Endocrinol"},{"key":"172_CR45","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1097\/00006231-200306000-00011","volume":"24","author":"F Lumachi","year":"2003","unstructured":"Lumachi F, Marzola MC, Zucchetta P, et al: Non-invasive adrenal imaging in primary aldosteronism. Sensitivity and positive predictive value of radiocholesterol scintigraphy, CT scan and MRI. Nucl Med Commun. 2003, 24: 683-8. 10.1097\/00006231-200306000-00011.","journal-title":"Nucl Med Commun"},{"key":"172_CR46","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/S0009-9260(05)81739-8","volume":"49","author":"JM Vincent","year":"1994","unstructured":"Vincent JM, Morrison ID, Armstrong P, Reznek RH: The size of normal adrenal glands on computed tomography. Clin Radiol. 1994, 49: 453-5. 10.1016\/S0009-9260(05)81739-8.","journal-title":"Clin Radiol"},{"key":"172_CR47","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1016\/j.surg.2008.07.025","volume":"144","author":"ML White","year":"2008","unstructured":"White ML, Gauger PG, Doherty GM, et al: The role of radiologic studies in the evaluation and management of primary hyperaldosteronism. Surgery. 2008, 144: 926-33. 10.1016\/j.surg.2008.07.025. discussion 33.","journal-title":"Surgery"},{"key":"172_CR48","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1210\/er.2002-0031","volume":"25","author":"G Mansmann","year":"2004","unstructured":"Mansmann G, Lau J, Balk E, Rothberg M, Miyachi Y, Bornstein SR: The clinically inapparent adrenal mass: update in diagnosis and management. Endocr Rev. 2004, 25: 309-40. 10.1210\/er.2002-0031.","journal-title":"Endocr Rev"},{"key":"172_CR49","doi-asserted-by":"publisher","first-page":"329","DOI":"10.7326\/0003-4819-151-5-200909010-00007","volume":"151","author":"MJ Kempers","year":"2009","unstructured":"Kempers MJ, Lenders JW, van Outheusden L, et al: Systematic review: diagnostic procedures to differentiate unilateral from bilateral adrenal abnormality in primary aldosteronism. Ann Intern Med. 2009, 151: 329-37.","journal-title":"Ann Intern Med"},{"key":"172_CR50","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1016\/j.surg.2004.06.051","volume":"136","author":"WF Young","year":"2004","unstructured":"Young WF, Stanson AW, Thompson GB, Grant CS, Farley DR, van Heerden JA: Role for adrenal venous sampling in primary aldosteronism. Surgery. 2004, 136: 1227-35. 10.1016\/j.surg.2004.06.051.","journal-title":"Surgery"},{"key":"172_CR51","first-page":"6762","volume":"61","author":"C Gicquel","year":"2001","unstructured":"Gicquel C, Bertagna X, Gaston V, et al: Molecular markers and long-term recurrences in a large cohort of patients with sporadic adrenocortical tumors. Cancer Res. 2001, 61: 6762-7.","journal-title":"Cancer Res"},{"key":"172_CR52","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1097\/01.hjh.0000202818.10459.96","volume":"24","author":"GP Rossi","year":"2006","unstructured":"Rossi GP, Ganzaroli C, Miotto D, et al: Dynamic testing with high-dose adrenocorticotrophic hormone does not improve lateralization of aldosterone oversecretion in primary aldosteronism patients. J Hypertens. 2006, 24: 371-9. 10.1097\/01.hjh.0000202818.10459.96.","journal-title":"J Hypertens"},{"issue":"Suppl 1","key":"172_CR53","doi-asserted-by":"publisher","first-page":"S143","DOI":"10.1148\/rg.25si055514","volume":"25","author":"N Daunt","year":"2005","unstructured":"Daunt N: Adrenal vein sampling: how to make it quick, easy, and successful. Radiographics. 2005, 25 (Suppl 1): S143-58. 10.1148\/rg.25si055514.","journal-title":"Radiographics"},{"key":"172_CR54","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1210\/jc.86.3.1066","volume":"86","author":"SB Magill","year":"2001","unstructured":"Magill SB, Raff H, Shaker JL, et al: Comparison of adrenal vein sampling and computed tomography in the differentiation of primary aldosteronism. J Clin Endocrinol Metab. 2001, 86: 1066-71. 10.1210\/jc.86.3.1066.","journal-title":"J Clin Endocrinol Metab"},{"key":"172_CR55","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1148\/radiology.198.2.8596821","volume":"198","author":"JL Doppman","year":"1996","unstructured":"Doppman JL, Gill JR: Hyperaldosteronism: sampling the adrenal veins. Radiology. 1996, 198: 309-12.","journal-title":"Radiology"},{"key":"172_CR56","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1111\/j.1365-2265.2008.03450.x","volume":"70","author":"WF Young","year":"2009","unstructured":"Young WF, Stanson AW: What are the keys to successful adrenal venous sampling (AVS) in patients with primary aldosteronism?. Clin Endocrinol (Oxf). 2009, 70: 14-7. 10.1111\/j.1365-2265.2008.03450.x.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"172_CR57","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1053\/meta.2002.30498","volume":"51","author":"M Omura","year":"2002","unstructured":"Omura M, Sasano H, Fujiwara T, Yamaguchi K, Nishikawa T: Unique cases of unilateral hyperaldosteronemia due to multiple adrenocortical micronodules, which can only be detected by selective adrenal venous sampling. Metabolism. 2002, 51: 350-5. 10.1053\/meta.2002.30498.","journal-title":"Metabolism"},{"key":"172_CR58","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1016\/S0140-6736(98)06102-9","volume":"353","author":"PM Stewart","year":"1999","unstructured":"Stewart PM: Mineralocorticoid hypertension. Lancet. 1999, 353: 1341-7. 10.1016\/S0140-6736(98)06102-9.","journal-title":"Lancet"},{"key":"172_CR59","doi-asserted-by":"publisher","first-page":"2454","DOI":"10.1210\/jc.2007-2734","volume":"93","author":"BM Biller","year":"2008","unstructured":"Biller BM, Grossman AB, Stewart PM, et al: Treatment of adrenocorticotropin-dependent Cushing's syndrome: a consensus statement. J Clin Endocrinol Metab. 2008, 93: 2454-62. 10.1210\/jc.2007-2734.","journal-title":"J Clin Endocrinol Metab"},{"key":"172_CR60","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.ando.2007.02.003","volume":"68","author":"MC Vantyghem","year":"2007","unstructured":"Vantyghem MC, Marcelli-Tourvieille S, Defrance F, Wemeau JL: [11beta-hydroxysteroide dehydrogenases. Recent advances]. Ann Endocrinol (Paris). 2007, 68: 349-56.","journal-title":"Ann Endocrinol (Paris)"},{"key":"172_CR61","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1097\/00000441-200112000-00002","volume":"322","author":"DG Warnock","year":"2001","unstructured":"Warnock DG: Liddle syndrome: genetics and mechanisms of Na+ channel defects. Am J Med Sci. 2001, 322: 302-7. 10.1097\/00000441-200112000-00002.","journal-title":"Am J Med Sci"},{"key":"172_CR62","doi-asserted-by":"publisher","first-page":"2236","DOI":"10.1172\/JCI118279","volume":"96","author":"L Pascoe","year":"1995","unstructured":"Pascoe L, Jeunemaitre X, Lebrethon MC, et al: Glucocorticoid-suppressible hyperaldosteronism and adrenal tumors occurring in a single French pedigree. J Clin Invest. 1995, 96: 2236-46. 10.1172\/JCI118279.","journal-title":"J Clin Invest"},{"key":"172_CR63","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1016\/j.jacc.2005.01.015","volume":"45","author":"P Milliez","year":"2005","unstructured":"Milliez P, Girerd X, Plouin PF, Blacher J, Safar ME, Mourad JJ: Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism. J Am Coll Cardiol. 2005, 45: 1243-8. 10.1016\/j.jacc.2005.01.015.","journal-title":"J Am Coll Cardiol"},{"key":"172_CR64","doi-asserted-by":"publisher","first-page":"2638","DOI":"10.1001\/jama.295.22.2638","volume":"295","author":"LA Sechi","year":"2006","unstructured":"Sechi LA, Novello M, Lapenna R, et al: Long-term renal outcomes in patients with primary aldosteronism. Jama. 2006, 295: 2638-45. 10.1001\/jama.295.22.2638.","journal-title":"Jama"},{"key":"172_CR65","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1210\/er.2007-0030","volume":"29","author":"JM Connell","year":"2008","unstructured":"Connell JM, MacKenzie SM, Freel EM, Fraser R, Davies E: A lifetime of aldosterone excess: long-term consequences of altered regulation of aldosterone production for cardiovascular function. Endocr Rev. 2008, 29: 133-54. 10.1210\/er.2007-0030.","journal-title":"Endocr Rev"},{"key":"172_CR66","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1161\/HYPERTENSIONAHA.108.122002","volume":"53","author":"J Matrozova","year":"2009","unstructured":"Matrozova J, Steichen O, Amar L, Zacharieva S, Jeunemaitre X, Plouin PF: Fasting plasma glucose and serum lipids in patients with primary aldosteronism: a controlled cross-sectional study. Hypertension. 2009, 53: 605-10. 10.1161\/HYPERTENSIONAHA.108.122002.","journal-title":"Hypertension"},{"key":"172_CR67","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1001\/archinternmed.2007.33","volume":"168","author":"C Catena","year":"2008","unstructured":"Catena C, Colussi G, Nadalini E, et al: Cardiovascular outcomes in patients with primary aldosteronism after treatment. Arch Intern Med. 2008, 168: 80-5. 10.1001\/archinternmed.2007.33.","journal-title":"Arch Intern Med"},{"key":"172_CR68","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1016\/j.surg.2005.09.027","volume":"138","author":"YW Novitsky","year":"2005","unstructured":"Novitsky YW, Kercher KW, Rosen MJ, Cobb WS, Jyothinagaram S, Heniford BT: Clinical outcomes of laparoscopic adrenalectomy for lateralizing nodular hyperplasia. Surgery. 2005, 138: 1009-16. 10.1016\/j.surg.2005.09.027.","journal-title":"Surgery"},{"key":"172_CR69","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1097\/01.ju.0000162045.68387.c3","volume":"174","author":"S Ishidoya","year":"2005","unstructured":"Ishidoya S, Ito A, Sakai K, et al: Laparoscopic partial versus total adrenalectomy for aldosterone producing adenoma. J Urol. 2005, 174: 40-3. 10.1097\/01.ju.0000162045.68387.c3.","journal-title":"J Urol"},{"key":"172_CR70","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1002\/bjs.4738","volume":"91","author":"A Assalia","year":"2004","unstructured":"Assalia A, Gagner M: Laparoscopic adrenalectomy. Br J Surg. 2004, 91: 1259-74. 10.1002\/bjs.4738.","journal-title":"Br J Surg"},{"key":"172_CR71","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1007\/s00104-008-1638-z","volume":"79","author":"MK Walz","year":"2008","unstructured":"Walz MK: [Adrenal tumors]. Chirurg. 2008, 79: 1087-94. 10.1007\/s00104-008-1638-z.","journal-title":"Chirurg"},{"key":"172_CR72","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1016\/j.surg.2007.09.001","volume":"142","author":"R Zarnegar","year":"2007","unstructured":"Zarnegar R, Lee J, Brunaud L, et al: Good blood pressure control on antihypertensives, not only response to spironolactone, predicts improved outcome after adrenalectomy for aldosteronoma. Surgery. 2007, 142: 921-9. 10.1016\/j.surg.2007.09.001. discussion -9.","journal-title":"Surgery"},{"key":"172_CR73","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1001\/archsurg.134.6.628","volume":"134","author":"WT Shen","year":"1999","unstructured":"Shen WT, Lim RC, Siperstein AE, et al: Laparoscopic vs open adrenalectomy for the treatment of primary hyperaldosteronism. Arch Surg. 1999, 134: 628-31. 10.1001\/archsurg.134.6.628.","journal-title":"Arch Surg"},{"key":"172_CR74","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1111\/j.1440-1681.1994.tb02520.x","volume":"21","author":"M Stowasser","year":"1994","unstructured":"Stowasser M, Klemm SA, Tunny TJ, Storie WJ, Rutherford JC, Gordon RD: Response to unilateral adrenalectomy for aldosterone-producing adenoma: effect of potassium levels and angiotensin responsiveness. Clin Exp Pharmacol Physiol. 1994, 21: 319-22. 10.1111\/j.1440-1681.1994.tb02520.x.","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"172_CR75","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1210\/jc.75.1.323","volume":"75","author":"K Nomura","year":"1992","unstructured":"Nomura K, Toraya S, Horiba N, Ujihara M, Aiba M, Demura H: Plasma aldosterone response to upright posture and angiotensin II infusion in aldosterone-producing adenoma. J Clin Endocrinol Metab. 1992, 75: 323-7. 10.1210\/jc.75.1.323.","journal-title":"J Clin Endocrinol Metab"},{"key":"172_CR76","doi-asserted-by":"publisher","first-page":"877","DOI":"10.7326\/0003-4819-121-11-199412010-00010","volume":"121","author":"JD Blumenfeld","year":"1994","unstructured":"Blumenfeld JD, Sealey JE, Schlussel Y, et al: Diagnosis and treatment of primary hyperaldosteronism. Ann Intern Med. 1994, 121: 877-85.","journal-title":"Ann Intern Med"},{"key":"172_CR77","doi-asserted-by":"publisher","first-page":"105","DOI":"10.7326\/0003-4819-131-2-199907200-00005","volume":"131","author":"RP Ghose","year":"1999","unstructured":"Ghose RP, Hall PM, Bravo EL: Medical management of aldosterone-producing adenomas. Ann Intern Med. 1999, 131: 105-8.","journal-title":"Ann Intern Med"},{"key":"172_CR78","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1016\/0002-9149(87)91030-7","volume":"60","author":"X Jeunemaitre","year":"1987","unstructured":"Jeunemaitre X, Chatellier G, Kreft-Jais C, et al: Efficacy and tolerance of spironolactone in essential hypertension. Am J Cardiol. 1987, 60: 820-5. 10.1016\/0002-9149(87)91030-7.","journal-title":"Am J Cardiol"},{"key":"172_CR79","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/S0022-5347(05)64028-1","volume":"169","author":"P Meria","year":"2003","unstructured":"Meria P, Kempf BF, Hermieu JF, Plouin PF, Duclos JM: Laparoscopic management of primary hyperaldosteronism: clinical experience with 212 cases. J Urol. 2003, 169: 32-5. 10.1016\/S0022-5347(05)64028-1.","journal-title":"J Urol"},{"key":"172_CR80","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1210\/jc.2007-2055","volume":"93","author":"P Mulatero","year":"2008","unstructured":"Mulatero P, Bertello C, Rossato D, et al: Roles of clinical criteria, computed tomography scan, and adrenal vein sampling in differential diagnosis of primary aldosteronism subtypes. J Clin Endocrinol Metab. 2008, 93: 1366-71. 10.1210\/jc.2007-2055.","journal-title":"J Clin Endocrinol Metab"},{"key":"172_CR81","doi-asserted-by":"publisher","first-page":"3637","DOI":"10.1210\/jc.2002-022051","volume":"88","author":"EA Espiner","year":"2003","unstructured":"Espiner EA, Ross DG, Yandle TG, Richards AM, Hunt PJ: Predicting surgically remedial primary aldosteronism: role of adrenal scanning, posture testing, and adrenal vein sampling. J Clin Endocrinol Metab. 2003, 88: 3637-44. 10.1210\/jc.2002-022051.","journal-title":"J Clin Endocrinol Metab"},{"key":"172_CR82","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1038\/jhh.2008.108","volume":"23","author":"M Murashima","year":"2009","unstructured":"Murashima M, Trerotola SO, Fraker DL, Han D, Townsend RR, Cohen DL: Change in the pattern of adrenal venous sampling over time in patients with primary aldosteronism. J Hum Hypertens. 2009, 23: 292-4. 10.1038\/jhh.2008.108.","journal-title":"J Hum Hypertens"},{"key":"172_CR83","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1097\/SLA.0b013e3181961d77","volume":"249","author":"RJ Auchus","year":"2009","unstructured":"Auchus RJ, Michaelis C, Wians FH, et al: Rapid cortisol assays improve the success rate of adrenal vein sampling for primary aldosteronism. Ann Surg. 2009, 249: 318-21. 10.1097\/SLA.0b013e3181961d77.","journal-title":"Ann Surg"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1750-1172-5-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T04:17:55Z","timestamp":1630469875000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/1750-1172-5-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5,19]]},"references-count":83,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["172"],"URL":"https:\/\/doi.org\/10.1186\/1750-1172-5-9","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,5,19]]},"assertion":[{"value":"22 October 2009","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2010","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2010","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"9"}}